During the past decade, Riverside Clinical Research conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 29 clinical trials were completed, i.e. on average, 80.6% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 17 clinical trials were completed. i.e. 154.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Riverside Clinical Research" #1 sponsor was "Pfizer" with 4 trials, followed by "Allakos Inc." with 3 trials sponsored, "Celgene" with 3 trials sponsored, "Phathom Pharmaceuticals, Inc." with 3 trials sponsored and "Renibus Therapeutics, Inc." with 3 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Riverside Clinical Research" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Loxo Oncology, Inc." with 2 trials as a collaborator, "BARC Global Central Laboratory" with 1 trials as a collaborator, "Bilcare Global Clinical Supplies" with 1 trials as a collaborator and "Camargo Pharmaceutical Services" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Riverside Clinical Research" are "Acute Kidney Injury" (3 trials), "Crohn Disease" (3 trials), "Hyperkalemia" (3 trials), "Overactive Bladder" (3 trials) and "Diabetes Mellitus, Type 2" (2 trials). Many other conditions were trialed in "Riverside Clinical Research" in a lesser frequency.

Most popular intervention types in "Riverside Clinical Research" are "Drug" (49 trials), "Other" (7 trials), "Biological" (3 trials), "Device" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "AK002" (3 trials), "Lansoprazole" (3 trials), "Ozanimod" (3 trials) and "Vonoprazan" (3 trials). Other intervention names were less common.

The vast majority of trials in "Riverside Clinical Research" are 49 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Riverside Clinical Research". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Riverside Clinical Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Riverside Clinical Research, 7 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".